| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
OPERATING EXPENSES | ||||||
Research and development | ||||||
63,500 | 34,300 | 14,307 | ||||
General and administrative | ||||||
19,512 | 8,961 | 4,937 | ||||
Total operating expenses | ||||||
83,004 | 43,230 | 19,244 | ||||
Loss from operations | ||||||
-83,004 | -43,230 | -19,244 | ||||
OTHER INCOME, NET | ||||||
Interest and other income, net | ||||||
1,976 | -44 | 83 | ||||
NET LOSS | ||||||
-81,028 | -43,274 | -19,161 | ||||
Other comprehensive income | ||||||
Foreign currency translation | ||||||
43 | 175 | -199 | ||||
COMPREHENSIVE LOSS | ||||||
-80,985 | -43,099 | -19,360 | ||||
Net loss per share attributable to common stockholders, basic and diluted | ||||||
-2.30 | -1.50 | -0.99 | ||||
Weighted average common shares outstanding, basic and diluted | ||||||
35,183 | 28,772 | 19,397 | ||||